Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
Open accessThe DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 9 sources its claims cite is checked for support yet.
Abstract
BACKGROUND: Positive association between obesity and survival after breast cancer was demonstrated in previous meta-analyses of published data, but only the results for the comparison of obese versus non-obese was summarised. METHODS: We systematically searched in MEDLINE and EMBASE for follow-up studies of breast cancer survivors with body mass index (BMI) before and after diagnosis, and total and cause-specific mortality until June 2013, as part of the World Cancer Research Fund Continuous Update Project. Random-effects meta-analyses were conducted to explore the magnitude and the shape of the associations. RESULTS: Eighty-two studies, including 213 075 breast cancer survivors with 41 477 deaths (23 182 from breast cancer) were identified. For BMI before diagnosis, compared with normal weight women, the summary relative risks (RRs) of total mortality were 1.41 [95% confidence interval (CI) 1.29-1.53] for obese (BMI >30.0), 1.07 (95 CI 1.02-1.12) for overweight (BMI 25.0-<30.0) and 1.10 (95% CI 0.92-1.31) for underweight (BMI <18.5) women. For obese women, the summary RRs were 1.75 (95% CI 1.26-2.41) for pre-menopausal and 1.34 (95% CI 1.18-1.53) for post-menopausal breast cancer. For each 5 kg/m(2) increment of BMI before, <12 months after, and ≥12 months after diagnosis, increased risks of 17%, 11%, and 8% for total mortality, and 18%, 14%, and 29% for breast cancer mortality were observed, respectively. CONCLUSIONS: Obesity is associated with poorer overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained. Being overweight is also related to a higher risk of mortality. Randomised clinical trials are needed to test interventions for weight loss and maintenance on survival in women with breast cancer.
Checked 2026-10-11 · 1 reference not checked yet
Overview
CoChat Summary
## TL;DR
This systematic review and meta-analysis of 82 follow-up studies found that higher BMI was associated with worse overall and breast cancer survival in women with breast cancer, whether BMI was measured before diagnosis, <12 months after, or ≥12 months after diagnosis. It also found some increased mortality risk in overweight and underweight women and evidence of a J-shaped BMI–total mortality relationship.
## Key findings
- Across 79 publications from 82 follow-up studies, the meta-analyses included 41,477 deaths (23,182 from breast cancer) among 213,075 breast cancer survivors.
- For total mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.41 (95% CI 1.29–1.53; 21 studies)
- <12 months after diagnosis: RR 1.23 (95% CI 1.12–1.33; 24 studies)
- ≥12 months after diagnosis: RR 1.21 (95% CI 1.06–1.38; 5 studies)
- For breast cancer mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.35 (95% CI 1.24–1.47; 22 studies)
- <12 months after diagnosis: RR 1.25 (95% CI 1.10–1.42; 12 studies)
- ≥12 months after diagnosis: RR 1.68 (95% CI 0.90–3.15; 2 studies; not statistically significant)
- Linear dose–response analyses showed increased risk per 5 kg/m² higher BMI:
- Total mortality: RR 1.17 before diagnosis, 1.11 <12 months after, 1.08 ≥12 months after
- Breast cancer mortality: RR 1.18 before diagnosis, 1.14 <12 months after
- The paper reports a J-shaped association for total mortality and notes that risks were also elevated in overweight and, in some analyses, underweight women.
## Methods
- Design: Systematic literature review and meta-analysis of follow-up studies of women with breast cancer.
- Data/sample: English-language articles from OVID MEDLINE and EMBASE through 30 June 2013, plus hand-searching; included studies had to report BMI and total or cause-specific mortality. Final meta-analyses used 79 publications from 82 follow-up studies.
- Main analysis: Random-effects categorical and dose–response meta-analyses, including non-linear dose–response models; heterogeneity assessed with Cochran Q and I², with subgroup/meta-regression, sensitivity analyses, and publication-bias checks using Egger’s test and funnel plots.
## Limitations
- The paper states that most studies did not adjust for co-morbidities and did not assess intentional weight loss; body weight and treatment information were often incomplete or unavailable.
- It notes that reverse causation may have affected studies assessing BMI in women with cancer and other illnesses, and that survival bias in survivor cohorts may underestimate associations.
- The text also says the review could not analyze race/ethnicity or treatment types because too few studies reported them; this is an evident limitation of the evidence base, not just the review.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 9 Not checked · 67 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BMI was significantly associated with breast cancer mortality.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
states an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The current systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre and postmenopausal breast cancer, regardless of when BMI is ascertained.”
- Also stated in: § discussion · boosted
“The present systematic literature review and meta-analysis of follow-up studies clearly supports that, in breast cancer survivors, higher BMI is consistently associated with lower overall and breast cancer survival, regardless of when BMI is ascertained.”
- Also stated in: § discussion · plain
“In conclusion, the present systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > Abstract
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § discussion · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared with normal weight women, for BMI before diagnosis, the summary RRs were 1.35 (95% CI 1.24–1.47, 22 studies) for obese women, 1.11 (95% CI 1.06–1.17, 21 studies) for overweight women, and 1.02 (95% CI 0.85–1.21, 8 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
47 more claims
Create a free account to see all 76 claims and to verify the 9 references still open.
- The quote only partly states this claim. 4
- It may state two separate claims as one. 16
- Probably not a substantial claim. 10
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“statistical analysis Categorical and dose-response meta-analyses were conducted using random-effects models to account for between-study heterogeneity[18].”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“To assess heterogeneity, we computed the Cochran Q test and I 2 statistic[35].”
MethodFood, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050 · cited 1×
“be obese and 958 million were overweight in 2008[3].”
BackgroundPublication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282 · cited 1×
“Small study or publication bias was examined by Egger’s test[36] and visual inspection of the funnel plots.”
MethodNutrition and physical activity guidelines for cancer survivors
Rock, C. L., Doyle, C., Demark‐Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., Bandera, E. V., Hamilton, K. K., Grant, B., McCullough, M., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21142 · Cited by 1,995
Self-citationGeneralized Least Squares for Trend Estimation of Summarized Dose–response Data
Orsini, N., Bellocco, R., & Greenland, S. (2006) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600103 · Cited by 1,241 · cited 1×
“generalised least-squares for trend estimation[25].”
The use of fractional polynomials to model continuous risk variables in epidemiology
Royston, P., Ambler, G., & Sauerbrei, W. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.5.964 · Cited by 1,066 · cited 1×
“The non-linear dose-response relationship between BMI and mortality was examined using the best-fitting second order fractional polynomial regression model[23], defined as the one with the lowest deviance.”
MethodFasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Protani, M., Coory, M., & Martin, J. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0990-0 · Cited by 962 · cited 3×
“A review published in 2010 reported statistically significant increased risks of 33% of both total and breast cancer mortality for obesity versus non-obesity around diagnosis[7].”
Background
Research works printed but not linked: 2
- Tobias A Assessing the influence of a single study in meta-analysis Stata Tech Bull 1999 47 15 17
- Donegan WL Jayich S Koehler MR The prognostic implications of obesity for the surgical cure of breast cancer Breast 1978 4 14 17
Cited by
Items 201–300 of 1,000
Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative
Simon, M. S., Beebe‐Dimmer, J., Hastert, T. A., Manson, J. E., Feliciano, E. M. C., Neuhouser, M. L., Ho, G. Y. F., Freudenheim, J. L., Strickler, H. D., Ruterbusch, J. J., et al. (2018) · Cancer · doi:10.1002/cncr.31230 · Cited by 56
Liu, X., Rulina, A., Choi, M. H., Pedersen, L., Lepland, J., Takle, S. T., Madeleine, N., Peters, S. D., Wogsland, C. E., Grøndal, S. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27734-2 · Cited by 57
Hoedjes, M., Nijman, I., & Hinnen, C. (2022) · Cancers · doi:10.3390/cancers14082026 · Cited by 55
“Depressive symptoms NS [4,8,30,32,36] *Higher levels of depressive symptoms & less likely to remain consistently sufficiently active [2] *Depression perceived barrier [30] NS [4,8,30,37]; NS for those with better fruit and vegetable and fiber intake at baseline [38] *For those with less fat consumption at baseline, in…”
BackgroundInfluentialLake, B., Damery, S. L., & Jolly, K. B. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062288 · Cited by 55
Interfering Role of ERα on Adiponectin Action in Breast Cancer
Naimo, G. D., Gelsomino, L., Catalano, S., Mauro, L., & Andò, S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00066 · Cited by 55
Crown-Like Structures in Breast Adipose Tissue: Early Evidence and Current Issues in Breast Cancer
Maliniak, M. L., Miller‐Kleinhenz, J. M., Cronin-Fenton, D. P., Lash, T. L., Gogineni, K., Janssen, E. A. M., & McCullough, L. E. (2021) · Cancers · doi:10.3390/cancers13092222 · Cited by 55
“This conclusion was based on three large meta-analyses of breast cancer mortality [3,4,28] and five epidemiologic studies of recurrence [29–33], with positive associations observed for distant recurrence.”
BackgroundBody mass index and weight change in relation to triple-negative breast cancer survival
Bao, P., Cai, H., Peng, P., Gu, K., Su, T., Shu, X., & Zheng, Y. F. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0700-7 · Cited by 55
“A systemic review that included 82 follow-up breast cancer studies showed that compared with normal weight women, obesity was associated with poorer overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI was ascertained [6].”
Tu, H., McQuade, J. L., Davies, M. A., Huang, M., Xie, K., Ye, Y., Chow, W., Rodriguez, A., & Wu, X. (2022) · The Innovation · doi:10.1016/j.xinn.2022.100344 · Cited by 54
Scholz, C., Andergassen, U., Hepp, P. G., Schindlbeck, C., Friedl, T. W. P., Harbeck, N., Kiechle, M. B., Sommer, H., Hauner, H., Friese, K., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3422-3 · Cited by 54
“The association between obesity and breast cancer risk is well known, and two recent large meta-analyses have confirmed that obesity constitutes a risk factor for breast cancer recurrence and poor survival [13, 14].”
BackgroundContribution of adipocytes in the tumor microenvironment to breast cancer metabolism
Lyu, X., Zhang, Q., Fares, H. M., Wang, Y., Han, Y., & Sun, L. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215616 · Cited by 53
Secretan, B., Dossus, L., Marant-Micallef, C., & His, M. (2019) · Bulletin du Cancer · doi:10.1016/j.bulcan.2019.04.008 · Cited by 53
Fu, M. R., Axelrod, D., Guth, A. A., Fletcher, J., Qiu, J. M., Scagliola, J., Kleinman, R., Ryan, C., Chan, N., & Haber, J. (2015) · Journal of Personalized Medicine · doi:10.3390/jpm5030326 · Cited by 52
Adipose Tissue Distribution and Survival Among Women with Nonmetastatic Breast Cancer
Bradshaw, P. T., Feliciano, E. M. C., Prado, C. M. M., Alexeeff, S., Albers, K. B., Chen, W. Y., & Caan, B. J. (2019) · Obesity · doi:10.1002/oby.22458 · Cited by 52
“Most researchers have considered mortality in relation to BMI (weight in kilograms divided by height in meters squared), a measure of overall body size, with several authors noting that among women with breast cancer, the nadir of the BMI-mortality relationship can appear to be in the overweight range (3).”
BackgroundLigibel, J. A., Pierce, L. J., Bender, C. M., Crane, T. E., Dieli-Conwright, C. M., Hopkins, J. O., Masters, G. A., Schenkel, C., Garrett-Mayer, E. S., Katta, S., et al. (2022) · Cancer · doi:10.1002/cncr.34231 · Cited by 52
Impact of Serum Lipid on Breast Cancer Recurrence
Jung, S. M., Kang, D., Güallar, E., Yu, J., Lee, J. E., Kim, S., Nam, S. J., Cho, J., & Lee, S. U. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092846 · Cited by 51
Weight Loss and Mortality in Overweight and Obese Cancer Survivors: A Systematic Review
Jackson, S. E., Heinrich, M., Beeken, R. J., & Wardle, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169173 · Cited by 51
Leptin and Immunological Profile in Obesity and Its Associated Diseases in Dogs
Cortese, L., Terrazzano, G., & Pelagalli, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102392 · Cited by 51
Cannioto, R. A., Attwood, K. M., Davis, E. W., Mendicino, L., Hutson, A. D., Zirpoli, G., Tang, L., Nair, N. M., Barlow, W. E., Hershman, D. L., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.11673 · Cited by 50
Feliciano, E. M. C., Kwan, M. L., Kushi, L. H., Chen, W. Y., Weltzien, E. K., Castillo, A., Sweeney, C., Bernard, P. S., & Caan, B. J. (2017) · Cancer · doi:10.1002/cncr.30637 · Cited by 50
Sakurai, M., Miki, Y., Takagi, K., Suzuki, T., Ishida, T., Ohuchi, N., & Sasano, H. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0863-0 · Cited by 50
The Role of Adipokines and Bone Marrow Adipocytes in Breast Cancer Bone Metastasis
Shin, E., & Koo, J. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144967 · Cited by 50
“Epidemiologic data show that postmenopausal women with obesity have a higher incidence of breast cancer, and obesity is related to breast cancer prognosis [102].”
BackgroundReeves, M. M., Terranova, C. O., WINKLER, E. A. H., McCarthy, N., Hickman, I. J., Ware, R. S., Lawler, S., Eakin, E., & Demark‐Wahnefried, W. (2021) · Nutrients · doi:10.3390/nu13114091 · Cited by 51
“9 kg/m2) have 30–40% reduced mortality risk compared to those with obesity (BMI ≥ 30 kg/m2) [8].”
BackgroundShariff‐Marco, S., Behren, J. V., Reynolds, P., Keegan, T. H. M., Hertz, A., Kwan, M. L., Roh, J. M., Thomsen, C., Kroenke, C. H., Ambrosone, C. B., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0932 · Cited by 49
“15 Higher BMI is associated with increased disease morbidity and mortality in general (42), and with higher mortality among breast cancer survivors (25, 43-49).”
BackgroundA Prospective Study of Obesity, Metabolic Health, and Cancer Mortality
Akinyemiju, T., Moore, J. X., Pisu, M., Judd, S. E., Goodman, M. G., Shikany, J. M., Howard, V. J., Safford, M. M., & Gilchrist, S. C. (2017) · Obesity · doi:10.1002/oby.22067 · Cited by 49
“These criteria define metabolic syndrome based on the presence of three or more of the following components: (1) an elevated waist circumference > 102 cm for males or> 88 cm for females; (2) elevated triglycerides 150 mg/dL or reported use of medication for elevated triglycerides; (3) reduced HDL cholesterol, defined…”
BackgroundBioelectrical Phase Angle in Patients with Breast Cancer: A Systematic Review
Morlino, D., Cioffi, I., Marra, M., Vincenzo, O. D., Scalfi, L., & Pasanisi, F. (2022) · Cancers · doi:10.3390/cancers14082002 · Cited by 49
“The excess of adipose tissue, which can be associated with loss of muscle tissue and body cell mass (BCM) as well as changes in fluid distribution [7], has negative effects on nutritional status and quality of life [8], and has been linked to a high risk of BC recurrence and mortality [9,10].”
BackgroundRacial/Ethnic Differences Affecting Adherence to Cancer Screening Guidelines Among Women
Hirth, J. M., Laz, T. H., Rahman, M., & Berenson, A. B. (2015) · Journal of Women s Health · doi:10.1089/jwh.2015.5270 · Cited by 49
“4–7 As a result, screening is particularly important among obese women, especially those from a minority background, who are more likely to be diagnosed with breast and cervical cancers.”
Barra, N. G., Fan, I. Y., Gillen, J. B., Chew, M. V., Marcinko, K., Steinberg, G. R., Gibala, M. J., & Ashkar, A. A. (2017) · Journal of Cancer Prevention · doi:10.15430/jcp.2017.22.4.260 · Cited by 48
“In pre- and post-menopausal breast cancer patients, obesity is associated with a marked reduction in survival compared to normal weight patients.(2) This increased risk of mortality may result from impaired innate immunity.”
BackgroundObesity and cancer treatment efficacy: Existing challenges and opportunities
Ross‐Driscoll, K., Gogineni, K., Subhedar, P. D., Lin, J. Y., & McCullough, L. E. (2019) · Cancer · doi:10.1002/cncr.31976 · Cited by 48
“adjustment for multiple confounders, including tumor stage.(40) Among a cohort of patients from a breast can-”
BackgroundThe Role of Obesity in Breast Cancer Pathogenesis
Glassman, I., Le, N., Asif, A., Goulding, A., Alcantara, C. A., Vu, A., Chorbajian, A., Mirhosseini, M., Singh, M., & Venketaraman, V. (2023) · Cells · doi:10.3390/cells12162061 · Cited by 47
“Increased breast cancer mortality with obese BMI has also been reported [66,70].”
BackgroundSong, E. J., Lee, C. W., Jung, S., Kim, B. N., Lee, K. S., Lee, S., Kang, H., Park, I. H., Lee, M. H., Kim, Y. J., et al. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4915-7 · Cited by 47
Franzoi, M. A., Eiger, D., Ameye, L., Ponde, N. F., Caparica, R., Angelis, C. D., Brandão, M., Desmedt, C., Cosimo, S. D., Kotecki, N., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa116 · Cited by 47
“A substantial body of evidence supports the relationship between being overweight or obese with worse outcomes in patients with early-stage BC, especially in estrogen receptor (ER)-positive BC (10).”
BackgroundObesity, cancer risk, and time-restricted eating
Das, M., & Webster, N. J. G. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10061-3 · Cited by 47
“Lastly, a meta-analysis of 82 studies including 213,075 breast cancer survivors found a 40% increased risk of mortality due to obesity in both pre- and post-menopausal women [45].”
BackgroundKent, E. E., Prestin, A., Gaysynsky, A., Galica, K., Rinker, R., Graff, K. A., & Chou, W. S. (2015) · Journal of Cancer Education · doi:10.1007/s13187-015-0824-1 · Cited by 46
“Evidence suggests that being overweight or obese is related to poorer quality of life [2], higher rates of cancer recurrence [3, 4], and increased mortality [5].”
BackgroundGoday, A., Barneto, I., García‐Almeida, J. M., Blasco, A., Lecube, A., Grávalos, C., de Icaya, P. M., Peñas, R. D. L., Monereo, S., Vázquez, L., et al. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1306-y · Cited by 46
Obesity and breast cancer: risk, outcomes, and future considerations.
Yung, R. L., & Ligibel, J. A. (2016) · PubMed · Cited by 46
Chamberlin, T., D’Amato, J. V., & Arendt, L. M. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0921-7 · Cited by 46
Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort
Maskarinec, G., Shvetsov, Y. B., Conroy, S. M., Haiman, C. A., Setiawan, V. W., & Marchand, L. L. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-5025-2 · Cited by 46
Tiainen, S., Masarwah, A., Oikari, S., Rilla, K. J., Hämäläinen, K. M., Sudah, M., Sutela, A., Vanninen, R. L., Ikonen, J., Tammi, R., et al. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05491-7 · Cited by 46
Morra, A., Jung, A. Y., Behrens, S., Keeman, R., Ahearn, T. U., Anton‐Culver, H., Arndt, V., Augustinsson, A., Auvinen, P., Freeman, L. E. B., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0924 · Cited by 46
Brown, J. C., Sarwer, D. B., Troxel, A. B., Sturgeon, K. M., DeMichele, A. M., Denlinger, C. S., & Schmitz, K. H. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06284-7 · Cited by 46
“Each 5 kg/m2 increase in BMI is associated with an 8–14% increase in the risk of disease recurrence or death in survivors of breast cancer [37, 38].”
BackgroundSerum N‐glycan analysis in breast cancer patients – Relation to tumour biology and clinical outcome
Haakensen, V. D., Steinfeld, I., Saldova, R., Shehni, A. A., Kifer, I., Naume, B., Rudd, P. M., Børresen‐Dale, A., & Yakhini, Z. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.08.002 · Cited by 46
“Both these parameters are associated with poor prognosis in previous studies (Chan et al., 2014; Olsen et al., 2009).”
ResultWeight gain during adjuvant endocrine treatment for early-stage breast cancer: What is the evidence?
Nyrop, K. A., Williams, G. R., Muss, H. B., & Shachar, S. S. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3874-0 · Cited by 47
Flote, V. G., Vettukattil, R., Bathen, T. F., Egeland, T., McTiernan, A., Frydenberg, H., Husøy, A., Finstad, S. E., Lømo, J., Garred, Ø., et al. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0225-4 · Cited by 45
“Given the increase in obesity and unfavorable metabolic profiles worldwide, and the observed negative effect of obesity on breast cancer development and prognosis [67], there is a need for improved knowledge regarding the association between lipids and lipoproteins and breast cancer.”
BackgroundResultSelf-citationvan Helmond, N., Timmerman, H., van Dasselaar, N. T., van der Pol, C. C., Olesen, S. S., Drewes, A. M., Vissers, K. C. P., Wilder‐Smith, O. H. G., & Steegers, M. A. H. (2017) · VBN Forskningsportal (Aalborg Universitet) · Cited by 45
Effects of obesity on hormonally driven cancer in women
Moley, K. H., & Colditz, G. A. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad8842 · Cited by 45
“For example, the effects of adiposity and weight gain in premenopausal years reflect persisting protection from earlier adiposity and an opposite or adverse effect of weight gain increasing cancer risk compared with that of normal BMI and no weight gain.”
BackgroundInfluentialCheng, I. C., Shariff‐Marco, S., Koo, J., Monroe, K. R., Yang, J., John, E. M., Kurian, A. W., Kwan, M. L., Henderson, B. E., Bernstein, L., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0055 · Cited by 45
Hidayat, K., Yang, C., & Shi, B. (2017) · Obesity Reviews · doi:10.1111/obr.12627 · Cited by 45
“Moreover, excess body fatness before and after diagnosis is associated with poorer survival in women with breast cancer (8).”
BackgroundObesity and Breast Cancer Outcomes: How Much Evidence Is Needed to Change Practice?
Goodwin, P. J. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.7503 · Cited by 45
Lopes‐Coelho, F., Gouveia-Fernandes, S., & Serpa, J. (2018) · Tumor Biology · doi:10.1177/1010428318756203 · Cited by 45
Role of MicroRNA Regulation in Obesity-Associated Breast Cancer: Nutritional Perspectives
Kasiappan, R., & Rajarajan, D. (2017) · Advances in Nutrition · doi:10.3945/an.117.015800 · Cited by 44
Clinical implications of low skeletal muscle mass in early-stage breast and colorectal cancer
Cespedes Feliciano, E., & Chen, W. Y. (2018) · Proceedings of the Nutrition Society · doi:10.1017/s0029665118000423 · Cited by 35
Lee, J. W., Ban, M. J., Park, J. H., & Lee, S. M. (2019) · Head & Neck · doi:10.1002/hed.25605 · Cited by 44
Morbid Obesity and Thyroid Cancer Rate. A Review of Literature
Masone, S., Velotti, N., Savastano, S., Filice, E., Serao, R., Vitiello, A., Berardi, G., Schiavone, V., & Musella, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091894 · Cited by 44
“Analyzing mechanisms leading to different tumors, such as breast and colorectal cancer [26,27], it is nowadays clear that chronic inflammation produces the activation and transcription of factors such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), STAT3, and activator protein 1 in pre-malig…”
BackgroundImpact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women
Chen, H., Ding, A., & Wang, M.-L. (2016) · SpringerPlus · doi:10.1186/s40064-016-2200-y · Cited by 44
Chen, L., Chubak, J., Boudreau, D. M., Barlow, W. E., Weiss, N. S., & Li, C. I. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0687 · Cited by 45
“Obesity is of particular importance, given its known positive associations with both diabetes and poor breast cancer outcomes.(30,31) However, given these correlations,”
Martel, S., Poletto, E., Ferreira, A. R., Lambertini, M., Sottotetti, F., Bertolini, I., Montemurro, F., Bernardo, A., Risi, E., Zanardi, E., et al. (2017) · The Breast · doi:10.1016/j.breast.2017.11.004 · Cited by 44
Bar, D., Lavie, O., Stein, N., Feferkorn, I., & Shai, A. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.09.005 · Cited by 43
Rodrigo, C., Tennekoon, K. H., Karunanayake, E. H., Silva, K. D., Amarasinghe, I., & Wijayasiri, A. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej16-0448 · Cited by 43
“Obesity is a well-known risk factor of breast cancer and several studies have shown this association is limited to post-menopausal women [31-33].”
BackgroundThe effect of environmental Bisphenol A exposure on breast cancer associated with obesity
Engin, A. B., & Engin, A. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103544 · Cited by 43
Meglio, A. D., Gbenou, A. S., Martin, É., Pistilli, B., Ligibel, J. A., Crane, T. E., Flaysakier, J.-D., Minvielle, É., Vanlemmens, L., Guénancia, C., et al. (2021) · Cancer · doi:10.1002/cncr.33565 · Cited by 43
Impact of cholesterol-pathways on breast cancer development, a metabolic landscape
González-Ortiz, A., Galindo‐Hernández, O., Acevedo, G. N. H., Hurtado-Ureta, G., & García‐González, V. (2021) · Journal of Cancer · doi:10.7150/jca.54637 · Cited by 43
Fucoxanthin Is a Potential Therapeutic Agent for the Treatment of Breast Cancer
Lau, T.-Y., & Kwan, H. Y. (2022) · Marine Drugs · doi:10.3390/md20060370 · Cited by 43
Adipose tissue-to-breast cancer crosstalk: Comprehensive insights
Wu, Y., Li, X., Li, Q., Cheng, C., & Zheng, L. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188800 · Cited by 43
Javed, S. R., Skolariki, A., Zameer, M. Z., & Lord, S. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02833-1 · Cited by 42
Survivorship: Nutrition and Weight Management, Version 2.2014
Denlinger, C. S., Ligibel, J. A., Are, M., Baker, K. S., Demark-Wahnefried, W., Dizon, D., Friedman, D. L., Goldman, M., Jones, L., King, A., et al. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0137 · Cited by 40
Turbitt, W. J., Collins, S. D., Meng, H., & Rogers, C. J. (2019) · Nutrients · doi:10.3390/nu11123012 · Cited by 42
Παπανδρέου, Π., Gioxari, A., Nimee, F., & Skouroliakou, M. (2021) · Nutrients · doi:10.3390/nu13062115 · Cited by 43
“Obesity is considered as a prime risk factor for postmenopausal BC and has been associated with low BC-specific survival [3] and all-cause mortality [4].”
BackgroundBao, J. J., Borja, N. A., Rao, M., Huth, J. F., Leitch, A. M., Rivers, A., Wooldridge, R. D., & Rao, R. (2015) · Cancer Medicine · doi:10.1002/cam4.388 · Cited by 41
“However, a recent meta-analysis showed that higher BMI was associated with higher overall and breast cancer-specific mortality with a linear dose–response, regardless of when BMI was ascertained [39].”
BackgroundAnderson, A. S., Dunlop, J., Gallant, S., Macleod, M., Miedzybrodzka, Z., Mutrie, N., O’Carroll, R. E., Stead, M., Steele, R. J., Taylor, R. S., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019410 · Cited by 41
“The research nurse was blinded to the randomisation.”
Weight, physical activity and breast cancer survival
McTiernan, A. (2018) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118000010 · Cited by 41
“The American Cancer Society/American Society for Clinical Oncology guidelines((1,67)) are based on expert opinion, and include recommendations that clinicians counsel survivors to: (1) achieve and maintain healthy weight, and if overweight or obese, limit consumption of high-energy foods and beverages and increase phy…”
BackgroundSelf-citationBandera, E. V., Demissie, K., Qin, B., Llanos, A. A. M., Lin, Y., Xu, B., Pawlish, K. S., Plascak, J. J., Tsui, J., Omilian, A. R., et al. (2020) · Journal of Cancer Survivorship · doi:10.1007/s11764-019-00849-8 · Cited by 41
Self-citationPreclinical Models to Study Obesity and Breast Cancer in Females: Considerations, Caveats, and Tools
Giles, E. D., & Wellberg, E. A. (2020) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-020-09463-2 · Cited by 41
Shang, L., Hattori, M., Fleming, G. F., Jaskowiak, N. T., Hedeker, D., Olopade, O. I., & Huo, D. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01397-9 · Cited by 41
The G Protein-Coupled Estrogen Receptor (GPER): A Critical Therapeutic Target for Cancer
Hall, K. A., & Filardo, E. J. (2023) · Cells · doi:10.3390/cells12202460 · Cited by 41
Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes
Golubnitschaja, O., & Sridhar, K. C. (2016) · Clinical & Experimental Metastasis · doi:10.1007/s10585-016-9816-8 · Cited by 40
Schoemaker, M. J., Nichols, H. B., Wright, L. B., Brook, M. N., Jones, M. E., O’Brien, K. M., Adami, H., Baglietto, L., Bernstein, L., Bertrand, K. A., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32892 · Cited by 40
“48 In conclusion, we have observed that both body size in early adulthood and subsequent weight gain are independently associated with reductions in premenopausal breast cancer risk.”
Maliniak, M. L., Cheriyan, A. M., Sherman, M. E., Liu, Y., Gogineni, K., Liu, J., He, J., Krishnamurti, U., Miller‐Kleinhenz, J. M., Ashiqueali, R., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01308-4 · Cited by 40
Al-Ismaili, Z., Al-Nasri, K., Al-Yaqoobi, A., & Al-Shukaili, A. K. (2020) · Sultan Qaboos University medical journal · doi:10.18295/squmj.2020.20.02.010 · Cited by 40
Cancer prevention through weight control—where are we in 2020?
Anderson, A. S., Renehan, A. G., Saxton, J., Bell, J. A., Cade, J. E., Cross, A. J., King, A., Ríboli, E., Sniehotta, F. F., Treweek, S. P., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01154-3 · Cited by 40
da Silva, B. R., Mialich, M. S., Cruz, L. P., Rufato, S., Gozzo, T. D. O., & Jordão, A. A. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.02.007 · Cited by 40
Obesity and Postmenopausal Hormone Receptor-positive Breast Cancer: Epidemiology and Mechanisms
Zuo, Q., Band, S., Kesavadas, M. P., & Madak‐Erdogan, Z. (2021) · Endocrinology · doi:10.1210/endocr/bqab195 · Cited by 41
Vegetable Oil Intake and Breast Cancer Risk: a Meta-analysis
Yue, X., Li, X., Sun, S., Wang, L., & Huang, T. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.12.5125 · Cited by 40
“Numerous studies have investigated a possible relation between obesity and breast cancer (Alegre et al., 2013; Chan et al., 2014), regardless of race or ethnic groups.”
BackgroundObeid, J., Stoyanova, R. S., Kwon, D., Patel, M. J., Padgett, K. R., Slingerland, J. M., Takita, C., Alperin, N. J., Yepes, M. M., & Zeidan, Y. H. (2016) · Clinical & Translational Oncology · doi:10.1007/s12094-016-1526-9 · Cited by 40
Can Nutrition Lower the Risk of Recurrence in Breast Cancer
Weigl, J., Hauner, H., & Hauner, D. (2018) · Breast Care · doi:10.1159/000488718 · Cited by 40
Fazzino, T. L., Sporn, N. J., & Befort, C. A. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3149-7 · Cited by 39
Wang, X., Hui, T., Wang, M.-Q., Liu, H., Li, R., & Song, Z. (2019) · Oncology Research and Treatment · doi:10.1159/000496548 · Cited by 39
Breast cancer survivorship in rural settings: a systematic review
Anbari, A. B., Wanchai, A., & Graves, R. S. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05308-0 · Cited by 39
Franzoi, M. A., Vandeputte, C., Eiger, D., Caparica, R., Brandão, M., Angelis, C. D., Hendlisz, A., Awada, A. H., Piccart, M. J., & de Azambuja, E. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05617-2 · Cited by 39
Kariagina, A., & Doseff, A. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415753 · Cited by 39
“Women who were obese at the time of breast cancer diagnosis had increased cancer-associated mortality [159,160].”
BackgroundHealth Behaviors and Lifestyle Interventions in African American Breast Cancer Survivors: A Review
Paxton, R. J., Garner, W., Dean, L. T., Logan, G., & Allen-Watts, K. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00003 · Cited by 39
“Similarly, two recent meta-analyses found that obesity was associated with a 41% increase in all-cause mortality and that overweight and obesity were associated consistently with treatment-related cardiotoxicity (42, 43).”
ResultVick, L. V., Canter, R. J., Monjazeb, A. M., & Murphy, W. J. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.07.004 · Cited by 38
Reeves, M. M., Terranova, C. O., Erickson, J. M., Job, J., Brookes, D. S. K., McCarthy, N., Hickman, I. J., Lawler, S., Fjeldsoe, B. S., Healy, G. N., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2858-0 · Cited by 38
Expected and paradoxical effects of obesity on cancer treatment response
Gallo, M., Adinolfi, V., Barucca, V., Prinzi, N., Renzelli, V., Barrea, L., Giacinto, P. D., Ruggeri, R. M., Sesti, F. F., Arvat, E., et al. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09597-y · Cited by 38
Pfeiler, G., Hlauschek, D., Mayer, E. L., Deutschmann, C., Kacerovsky-Strobl, S., Martín, M., Meisel, J. L., Zdenkowski, N., Loibl, S., Balić, M., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00126 · Cited by 38
Lu, C., Chubak, J., Boudreau, D. M., Barlow, W. E., Weiss, N. S., & Li, C. I. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0346 · Cited by 38
Jabo, B., Lin, A. C., Aljehani, M. A., Ji, L. N., Morgan, J. W., Selleck, M. J., Kim, H. Y., & Lum, S. S. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6663-7 · Cited by 38
Weight trajectories in women receiving systemic adjuvant therapy for breast cancer
Nyrop, K. A., Deal, A. M., Shachar, S. S., Park, J., Choi, S. K., Lee, J. T., O’Hare, E. A., Wheless, A., Carey, L., & Muss, H. B. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05501-8 · Cited by 38
Huang, J., Wang, Y., Lo, S. J., Tseng, L., Chen, D., Wu, Y., Hou, M., & Yuan, S. F. (2019) · Cancers · doi:10.3390/cancers12010029 · Cited by 37
“Obesity is increasingly seen as one of the most important modifiable risk factors in breast cancer, with epidemiological studies indicating that obese, postmenopausal women exhibit both an increased incidence [2] and poorer prognostic outcomes [3].”
BackgroundKunin, A. A., Sargheini, N., Birkenbihl, C., Moiseeva, N., Fröhlich, H., & Golubnitschaja, O. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00229-8 · Cited by 37
Bruinsma, T. J., Dyer, A.-M., Rogers, C. J., Schmitz, K. H., & Sturgeon, K. M. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1029 · Cited by 37
“Multiple cross-sectional studies and reviews suggest that diet and exercise habits play an important role in both risk and recurrence of breast cancer (10, 11).”
Background
Metadata
- Authors
- Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T.
- Affiliations
- Imperial College London (GB)
- Norwegian University of Science and Technology (NO)
- Rutgers, The State University of New Jersey (US)
- University of Leeds (GB)
- Fred Hutch Cancer Center (US)
- Oslo University Hospital (NO)
- Newcastle University (GB)
- Corresponding author
- Chan, D.S.M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 25
- Issue
- 10
- Pages
- 1901-1914
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC4176449
- OpenAlex
- W2149466392
- Cited by
- 1,165
- References
- 123
- Citations by year
- 2026: 57 · 2025: 69 · 2024: 97 · 2023: 117 · 2022: 132 · 2021: 117 · 2020: 121 · 2019: 103 · 2018: 97 · 2017: 98 · 2016: 85 · 2015: 58 · 2014: 12
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1878 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc-nd)
- HighWire Press Open Archive (submittedVersion)
- Funders
- World Cancer Research Fund International (2007/SP01)
- World Cancer Research Fund International/American Institute for Cancer Research
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- body mass index, breast cancer, obesity, overweight, underweight, survival, mortality, cause-specific mortality, menopausal status, weight loss interventions, cancer survivorship
- MeSH terms
- Breast Neoplasms, Female, Follow-Up Studies, Humans, Obesity, Prognosis, Risk Factors, Body Mass Index, Randomized Controlled Trials as Topic, MEDLINE, Survivors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.